Stay updated on AMX0035 in ALS: Phoenix Clinical Trial
Sign up to get notified when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.

Latest updates to the AMX0035 in ALS: Phoenix Clinical Trial page
- Check6 days agoChange DetectedThe page shows a minor revision update from v3.3.1 to v3.3.2, with no changes to study data, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedThe study page's revision indicator updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedThe government funding lapse notice regarding NIH operations has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedNo significant content or structural changes detected between the two screenshots. Only minor visual adjustments (layout/formatting) appear, with core study details unchanged.SummaryDifference0.3%

- Check63 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%

- Check70 days agoChange DetectedVersion update to v3.1.0 accompanies removal of several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and no new substantive topics added.SummaryDifference0.4%

Stay in the know with updates to AMX0035 in ALS: Phoenix Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.